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Abstract: 
Centrosomes, composed of a pair of centrioles surrounded by pericentriolar material (PCM), are 
the main microtubule-organizing centers in eukaryotic cells involved in essential cell processes 
including nucleation and organization of the mitotic spindle. Heritable genetic defects in 
centrosomal components resulting in centrosome misregulation have been linked with 
developmental diseases such as primordial dwarfism and microcephaly. Centrosomes mature and 
duplicate once per cell cycle in a tightly controlled manner through the recruitment of hundreds of 
proteins, but explicit details on its organization have remained elusive. In particular, the role of 
centrioles is to recruit and organize the surrounding PCM, yet it is not well understood how these 
structures are physically linked. Using Drosophila as a model organism, our study aimed to 
elucidate the structural scaffolds that bridge the centrioles and PCM through characterization of 
several candidate proteins shown to associate through a directed yeast 2 hybrid screen. These 
proteins – Asl, CNN, PLP, and Sas-4 – were characterized through biochemical analysis and 
through structural analysis using X-ray crystallography to understand how they form a scaffold in 
order to recruit maturation and duplication factors to the centrosome. We have shown that several 
of the protein fragments chosen for crystallographic studies are able to localize independently to 
the centrosome in Drosophila S2 cells indicating they contain important targeting and/or binding 
domains. Biochemical analyses have revealed binding interactions and secondary structure of 
important protein fragments. Through bacterial cloning and expression, we have purified protein 
for all fragments of interest, and crystallization trials are under way in order to obtain high-
resolution structures of interaction domains, both independently and in complex with one another. 
By understanding the structural and biochemical properties of these proteins, we can further 
elucidate the regulation of centrosomes in vivo and more fully understand how their misregulation 
can lead to disease. 
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Introduction: 
In eukaryotes, the main microtubule-organizing center in the cell is the centrosome, a non-
membrane-bound organelle involved in such essential cell processes as organization of the 
microtubule cytoskeleton and mitotic spindle, regulation of protein trafficking and cell division, 
and establishment and maintenance of cell polarity (1, 2). Centrosomes are composed of two 
structural elements: a centriole, shown to be an electron-dense cylinder of proteins that exhibits 
distinctive nine-fold symmetry, and surrounding pericentriolar material (PCM) (3). The PCM was 
previously thought to be an amorphous cloud of proteins; however, recent super-resolution 
microscopy studies have shown the PCM in Drosophila to contain distinct structural layers. The 
innermost layers closest to the centrioles contain primarily scaffolding proteins such as Sas-4, Asl, 
and PLP. The outermost layers primarily contain microtubule recruiting and organizing proteins 
such as Spd-2, γ-TURC, and CNN (4 - 6). Several hundred other proteins are concentrated within 
the PCM, a fact that highlights the centrosome’s role as a coordination center of the cell (7). The 
recruitment and subsequent organization of these proteins is a complex process that strictly 
controls the regulation of centrosome function. However, explicit details on how they are 
organized to form a functional centrosome are currently poorly understood. 
Like the cell’s genetic material, centrioles are duplicated once per cell cycle in S-phase and 
continue on to from the poles of the mitotic spindle. Centriole and PCM proteins recruited at 
precise times during the cell cycle regulate the process of assembly and duplication of centrioles 
and the subsequent maturation of the centrosome (1). The centrosome remains dynamic throughout 
the cell cycle, exhibiting the ability to change its microtubule nucleation capacity, especially 
during the onset of mitosis. This changing nucleation capacity is termed centrosome maturation, 
and is most clearly observed as the dramatic expansion of the PCM right before mitosis. This 
process of expansion requires the recruitment of many centrosomal proteins, such as γ-tubulin (8, 
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9, reviewed in 10).  It is during this time that centrosomes nucleate the microtubules that will form 
the mitotic spindle, a crucial step for proper cell division. In organizing the mitotic spindle, 
centrosomes facilitate accurate segregation of chromosomes. Therefore, tight regulation of 
centrosome composition and number is imperative to ensure mitotic defects do not occur. This 
concept is corroborated by a correlation between supernumerary centrosomes arising due to 
deregulation of centrosome biogenesis and aneuploidy, polyploidy, and chromosome 
fragmentation (11, 12). These abnormal cellular conditions are implicated in tumorigenesis, 
although whether these conditions are corollary or causative has yet to be established (13). Studies 
have also shown a link between heritable point mutations in centrosomal proteins and 
developmental diseases, including primordial dwarfism and microcephaly (14, 15, 16).  
Among the proteins implicated in the development of these diseases are Asterless (Asl), 
Centrosomin (CNN), Pericentrin-Like Protein (PLP), and Spindle Assembly defective-4 (Sas-4), 
each of which have identified human orthologues CEP152 (14), CDK5RAP2 (17), Pericentrin 
(18), and CPAP (19), respectively. Each of these proteins plays crucial roles either in centriole 
duplication, PCM recruitment or both, in flies as well as in humans. For example, Sas-4 and its 
human orthologue CPAP have been shown to be essential for centriole replication. Cells treated 
with sas-4 RNAi and thus lacking Sas-4 function were observed to contain only one centrosome 
and were defective in S-phase progression (20). Reduced levels of Sas-4 result in centrosomes 
with significantly less PCM, while in contrast, overexpression of Sas-4 leads to elongated 
centrioles with associated PCM as well as acentriolar centrosomes (21 - 24). Clearly, Sas-4 is 
involved in both centriole duplication and the recruitment of essential PCM components; however, 
the mechanistic details behind these roles remain unclear. 
Asl is also essential for centriole duplication and PCM recruitment through its role as a 
molecular scaffold for other centrosomal proteins. It has been shown to colocalize with Sas-4, 
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CNN, and PLP near the centriole (25 - 30). In flies mutant for Asl, the stabilization and 
maintenance of the PCM is severely disrupted and the centrioles are often absent altogether, 
indicating a lack of structural integrity at the centrosome (28, 29). Both Asl and PLP exist at the 
centrosome in an extended conformation with their carboxyl-termini facing inwards towards the 
center and their amino-termini facing outwards, extending from the centriole’s outer wall into the 
PCM (5). This organization emphasizes their potential roles as scaffolding proteins and raises the 
possibility that they form a physical bridge linking the centrioles with the PCM and thus contribute 
to a structurally sound centrosome. However, it is not known exactly how Asl and PLP bind and 
interact with their partners to form such a bridge due to a lack of structural studies. 
Other proteins essential for proper PCM formation are CNN and PLP. Centrioles are able 
to control the total amount of PCM they organize throughout the cell cycle by regulating the rate 
of CNN incorporation into existing PCM (31). The human orthologue of CNN, CDK5RAP2, 
interacts with the human orthologue of PLP, Pericentrin. This interaction is necessary for correct 
centrosome maturation and bipolar spindle formation (32). Interestingly, a conserved domain 
known as the PACT domain is located within PLP, Pericentrin, and a similar protein in humans, 
AKAP450 (33, 34). This domain is sufficient for centrosomal targeting and contains specific 
Calmodulin (CaM) binding sites (33). In fact, interaction of CaM with the PACT domain is 
required for proper targeting of PLP to the centrosome. A point mutation disrupting the PACT-
CaM interaction within PLP causes inefficient centrosomal targeting and highly disorganized PCM 
(35), likely due to the loss of the scaffolding function of PLP. Thus, CaM also plays a crucial role 
in the organization of PCM and regulation of the centrosome. 
Clearly Asl, CNN, PLP, and Sas-4 are intimately linked through their functional 
association at the centrosome. Interestingly, not only do these proteins exhibit similar functional 
roles, but they have also been shown to associate in a cytoplasmic complex known as S-CAP, 
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which also contains CP-190 and 𝛾-tubulin. It has been proposed that this S-CAP complex forms 
as a result of Sas-4 acting as a scaffold for pre-assembled cytoplasmic complexes before tethering 
them at the centrosome (36). The S-CAP complex is held at the centrosome via Sas-4 during 
centrosome maturation, providing an initial layer of PCM upon which more PCM is added later 
(36). In cells mutant for sas-4 that are unable to properly form S-CAP complexes, centrosomes are 
still present but with greatly reduced levels of PCM (36). Needless to say, without any one of the 
proteins present in the S-CAP complex, centrosomes would fail to form properly, leading to 
microtubule-associated mitotic defects such as aneuploidy and chromosome fragmentation. Thus, 
by studying the structural and biochemical properties of these centrosomal proteins both 
independently and in complex with one another, we can more deeply understand how centrosome 
duplication and maturation is regulated in vivo. 
Although functional studies have elucidated some roles of Asl, CNN, and PLP, no studies 
have yet been published on the structural and biophysical characteristics of these proteins. We 
hypothesized that conserved structural domains in Asl and PLP serve as key interaction sites 
involved in protein complex formation with Sas-4 and CNN in order to act as bridge proteins 
between centriole and PCM components. Our study aimed to characterize these proteins both 
through biochemical analysis and structural analysis. Biochemical data can give insight into the 
specific binding interactions between these centriole bridge components to help determine how 
they form building blocks for a larger ordered structure within the centrosome. High-resolution 
structural models obtained through X-ray crystallography can allow a deeper understanding of 
how these scaffolds establish contacts at the centriole wall and recruit PCM. Overall, 
characterization of these proteins will allow a more thorough understanding of the duplication and 
maturation of centrosomes, and thus how their misregulation can lead to disease. 
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Materials and Methods: 
Cloning, Expression, and Purification of Protein Fragments 
 All fragments used in this study were designed based off of secondary structure predictions. 
Fragments of full-length constructs shown in Figure 1 were amplified through PCR and ligated 
into bacterial expression vectors containing either a 6X-histidine (HIS) tag or Glutathione S-
transferase (GST) tag. All constructs were verified by sequencing. These vectors were transformed 
into BL21 E. coli cells, grown at 37°C to OD600 of 0.6 and induced with 0.1 mM isopropyl β-D-1-
thiogalactopyranoside (IPTG). After induction, cells were shifted to 18°C for 18 hours. Cell pellets 
were collected by centrifugation and stored in Buffer A (25mM Tris pH 8.00, 300mM NaCl, 10mM 
Imidazole, 0.1% BME) or CaM Storage Buffer (20mM HEPES pH 7.5, 100mM NaCl, 10mM 
CaCl2) in the case of CaM and CAPS buffer (25mM CAPS pH 10.00, 0.1% BME) in the case of 
Asl 842-961, at -20°C. Cells were lysed in their respective storage buffers by sonication and then 
centrifuged for 45 minutes at 36,000 g to obtain clarified lysate supernatant. PMSF was used 
during sonication to limit protease activity. Supernatant of HIS-tagged constructs was loaded onto 
an equilibrated Ni-NTA column and washed extensively with Buffer A. Using an AKTA FPLC 
system, the protein was eluted from the column by running a linear gradient from 100% Buffer A 
to 100% Buffer B (25mM Tris pH 8.00, 300mM NaCl, 300mM Imidazole, 0.1% BME). Full-
length CaM was purified on an anion-exchange column following purification on the Ni-NTA 
column in a similar manner using Q Buffer A (25mM Tris pH 8.00, 10mM NaCl, 0.1% BME) and 
Q Buffer B (25mM Tris pH 8.00, 1M NaCl, 0.1% BME). Supernatant of GST-tagged constructs 
was loaded onto an equilibrated Glutathione Sepharose column and washed extensively with GST 
Buffer A (25mM Tris pH 8.00, 300mM NaCl, 0.1% BME). The protein was batch eluted from the 
column in 50 mL GST Buffer B (25mM Tris pH 8.00, 25mM reduced glutathione, 300mM NaCl 
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0.1% BME). In the case of PACTF, cells expressing either HIS-CaM or GST-PACTF were 
sonicated together, and the clarified supernatant was purified first over a Ni-NTA column, then 
over a GST-column, in the same manner as previously described. Fractions containing protein 
were pooled and dialyzed overnight into appropriate storage buffers containing PreScisson 
protease to cleave the HIS-tag and/or GST-tag. All dialyzed protein fractions were run through a 
Glutathione Sepharose column to remove HIS-PreScission Protease, free GST-tag, and/or 
uncleaved protein, then concentrated, flash frozen in liquid nitrogen, and stored at -80°C. 
Transfection and Fixation of S2 Cells 
Drosophila melanogaster S2 cells were resuspended in Schneider’s media (5% FBS, 
anti/anti). One milliliter of resuspended cells was centrifuged for 3 minutes at 200 g to pellet the 
cells. The pellet was resuspended in 100 μL Amaxa solution with 1 μg of vector containing the 
protein of interest fused to an N-terminal GFP-tag under an actin promoter. This solution was 
placed in a cuvette and cells were electroporated. The cells were then resuspended in 2 mL of 
Schneider’s media and plated in a 6-well culture dish. Forty-eight hours post-transfection, cells 
were plated on Concanavalin A-coated coverslips and allowed to adhere for 30 minutes. The media 
was aspirated from the dish and the cells were washed with 1X PBS. The cells were then washed 
with ice cold (-20⁰C) 100% dry MeOH. The dish was again washed with ice cold 100% dry MeOH 
and incubated with the MeOH at -20⁰C for 20 minutes. After aspirating away the MeOH, the dish 
was washed three times with 1X PBS. 
Staining of S2 Cells 
For the Asl fragments, rabbit anti-PLP was used as the primary antibody at a 1:1000 
dilution, Guinea Pig anti-rabbit 568 was used as the secondary antibody at a 1:1000 dilution, and 
Rabbit:Phosphohistone 3 at a 1:1000 dilution was used to stain mitotic chromatin. For the CNN 
8 
 
fragment, the primary antibody used was Guinea Pig anti-Asl at a 1:30,000 dilution, the secondary 
antibody used was Rabbit anti-Guinea Pig 568, and Rabbit:Phosphohistone 3 was used in the same 
manner.  All antibodies were diluted in a 1X PBS/5% Normal Goat Serum solution. The prepared 
coverslips were incubated with primary antibody for 30 minutes and then washed three times with 
1X PBS. These steps were repeated with the secondary antibody and with PH3. The coverslips 
were then mounted on slides. 
Circular Dichroism (CD) Analysis 
CD spectra were recorded on a Cirascan Plus: Steady State Circular Dichroism/ 
Fluorescence spectrometer with titration and automated temperature ramping capabilities at 20°C 
using a 0.1 cm path-length cuvette. Asl 842-961 was incubated in several buffers of varying pH 
(20mM sodium citrate for pH 3, 20mM sodium acetate for pH 5, and 20mM sodium phosphate for 
pH 7) at a concentration of 0.1 mg/mL.  In order to compare CD spectra recorded at different pH 
values, the concentration of each sample was kept constant and the CD spectra were recorded after 
buffer exchanging to each pH. 
Isothermal Titration Calorimetry (ITC) Analysis 
Prior to ITC analysis, PACTP was desalted on a G-25 Sephadex Quick Spin protein 
column. ITC was performed on CaM and PACTP using a MicroCal Auto-iTC200 fully automated 
isothermal titration calorimeter. The experiment was carried out at 26°C. The sample cell was 
filled with CaM (15 µM solution) in 10 mM HEPES, pH 7.4, 100 mM NaCl, and 2 mM EGTA. 
The peptide was diluted to a concentration of 171 µM in the same buffer. The injection volumes 
were 2 µl each with a 180 second delay between each injection. Data analysis was performed with 
Origin® software using fitting models to calculate reaction stoichiometry (n), binding constant 
(Kd), enthalpy (∆H), and entropy (∆S).  
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Crystallization Trials 
 Trials began for purified proteins using broad screening kits HR2-110 and HR2-126 
commercially available from Hampton Research. Broad screens were set-up using the hanging-
drop vapor diffusion method in 24-well Linbro trays (Hampton) for Asl 842-961, CNN F1, Asl 
626-719+CNN F1, Asl 842-961+CNN F1, and CaM+PACTP (see Figure 1). Drops were set by 
adding 2 µL of protein to 2 µL of well solution. Trays were incubated at 20°C. Proteins used in 
cocrystallization trials were incubated together at molar ratios on ice for one hour before setting 
the drops. Once possible crystallization conditions were identified in the broad screens, narrower 
optimization screening conditions were employed.  
Optimization conditions for Asl 842-961 used a screen of Ammonium fluoride that varied 
down the tray in 0.05 M increments from 0.05 M to 0.2 M and varied Polyethylene glycol (PEG) 
3350 across in 5% increments from 5% to 30% (weight/volume). The second optimization crystal 
tray varied the percentage of PEG across in 5% increments from 5% to 30%, and varied the 
molecular weight of the PEG (PEG-1500, -4000, -6000, and -8000)  down while maintaining a 
constant concentration of CAPS buffer (stock 1M CAPS pH 10.00, 0.1% 2-mercaptoethanol) of 
either 0.1 M or 0.3 M. After the hanging drops equilibrated over the course of seven days, a 
potential crystallization hit was identified, and a second optimization crystal tray was set up 
varying PEG 8000 across in 2.5% increments from 17.5% to 30% (weight/volume) and a varying 
CAPS buffer concentration down in 0.05 M increments from 0.05 M to 0.2 M. 
CNN 1-365 was screened at a concentration of 10 mg/mL and a possible crystal condition 
was identified in condition #15 of HR2-110. Several optimizations of this condition were tested. 
The first optimization tray used a screen of Ammonium sulfate that varied across in 0.05 M 
increments from 0.1 M to 0.35 M and varied PEG 8000 down in 4% increments from 24% to 36%. 
Sodium cacodylate was kept at a constant concentration of 0.1 M pH 6.5 throughout the tray. Drops 
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were streak-seeded with microseeds from the original condition. A second optimization tray 
lowered PEG 8000 to 14% to 20%, and the tray was incubated at 4°C. 
Co-crystallization trials for Asl 842-961+CNN 1-365 were screened using various molar 
ratios of Asl and CNN created by mixing fixed amounts of the two components from the following 
individual stocks: 4 mM of Asl 842-961 and 0.16 mM CNN 1-365 both in a CAPS buffer. Drops 
were streak-seeded with carbon nanotubes at a concentration of 0.1 mg/mL. Possible crystal 
conditions were identified in condition #47 of HR2-110. Two optimizations of this condition were 
tested. The first optimization used a screen that varied Ammonium sulfate across in 0.5 M 
increments from 0.5 M to 3.0 M and varied Sodium acetate pH 4.6 down in 0.05 M increments 
from 0.1 M to 0.25 M. A second optimization tray was set-up identical to the first, and this tray 
was incubated at 4°C. 
Co-crystallization trials of Asl 626-719+CNN 1-365 were conducted in the same manner 
as the broad screening trials of Asl 842-961+CNN 1-365, however at ratios of 1.06 mM Asl:0.276 
mM CNN and 2.12 mM Asl:0.276 mM CNN. Rod-shaped crystals appeared in condition #44 of 
HR2-126. An optimization screen was set-up by varying Ammonium phosphate across in 0.05 M 
increments from 0.1 M to 0.35 M and varying PEG 3350 down in 2% increments from 14% to 
20%. Asl and CNN were incubated at a ratio of 0.708 mM Asl:0.184 mM CNN for the 
optimization. This optimization tray was repeated using molar ratios of 0.185 mM Asl:0.185 mM 
CNN and 0.370 mM Asl:0.185 mM CNN.  
A complex of CaM with the PACT peptide (PACTP) was created by first dissolving a 
minimal amount of PACTP in 100% DMSO prior to dilution in CaM storage buffer, then adding 
solubilized PACTP to a 0.6 mM solution of CaM in a 1:1.5 CaM:PACTP ratio. An optimization 
screen was set-up based on conditions from the solved structure PDB ID 4DS7 for CaM bound by 
a peptide from the yeast spindle pole body protein Spc110 (37). This tray was set-up by varying 
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Sodium acetate pH 4.5 in 0.2 M increments across from 0.6 M to 0.16 M and varying Ammonium 
sulfate down in 0.1 M increments from 0.5 M to 0.8 M with a constant concentration of 0.5 M 
Guanidine hydrochloride throughout the tray. 
Expression and Solubility Tests 
S. pombe Pcp1 872-1208, S. pombe Pcp1 917-1208, H. sapiens PCNT 3119-3337, and H. 
sapiens AKAP450 3664-3744 were transformed into BL21 E. coli cells, grown at 37°C to OD600 
of 0.6 and induced with 0.1 mM IPTG. After induction, cells were shifted to 18°C for 18 hours. 
Cell pellets were collected by centrifugation and stored in Buffer A at -20°C. Cells were lysed by 
sonication and then centrifuged for 45 minutes at 36,000 g to obtain clarified lysate supernatant. 
PMSF was used during sonication to limit protease activity. 
Results: 
Bacterial expression and column chromatography yielded pure protein for all fragments of 
interest 
All protein fragments were derived from full-length Drosophila melanogaster proteins 
(Fig. 1). Asl and CNN full-length proteins were divided into smaller fragments in order to isolate 
as much predicted secondary structure as possible, with the expectation of obtaining more stable 
fragments during expression and purification. All Asl and CNN fragments as well as full-length 
CaM were purified for biochemical and structural analysis (Fig. 3, Fig. 4). They expressed well in 
BL21 E. coli cells induced with IPTG and remained soluble during the purification process.  
A conserved minimal region of the PACT domain in PLP known to bind CaM (reference 
#33; see Fig. 2), labeled as PACTF in Figure 1, expressed well in E. coli cells. However, this 
fragment was fairly insoluble when purified independently. PACTF showed a greater degree of 
solubility when copurified with CaM, which confirms the presence of binding between them (Fig. 
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4). However, we only observed GST-PACTF to be soluble when copurified with CaM, prior to 
cleavage of the GST-tag. Due to PACTF having a similar molecular weight to CaM, its presence 
as a soluble band after GST-tag cleavage cannot be determined by our SDS-PAGE gel (Fig. 4). A 
better resolved SDS-PAGE gel will determine if PACTF continues to remain soluble after 
cleavage. Due to the limited solubility of PACTF, a smaller region of the conserved PACT domain, 
labeled as PACTP in Figure 1, was synthesized as a low molecular weight peptide in order to aid 
in biochemical and structural analyses.  
Asterless and Centrosomin fragments exhibit robust localization to centrosomes 
In order to assess the ability of Asl F1, F2, F3 and CNN F1 to localize to the centrosome 
in vivo, we transfected Drosophila melanogaster S2 cells with GFP-tagged versions of these 
fragments. Endogenous PLP and Asl were tagged with red fluorescent antibodies and served as 
centrosomal markers within GFP-Asl and GFP-CNN transfected cells, respectively. As can be seen 
in Figure 5 by the presence of green fluorescence at the red fluorescently marked centrosome, all 
three Asl fragments and CNN F1 robustly localized to the centrosome. Phosphohistone 3 was also 
used to stain mitotic chromatin, however no Phosphohistone 3 staining was observed on the slides. 
These localization studies demonstrated the ability of each fragment to independently localize to 
the centrosome, likely mediated by interactions with other centrosomal proteins.   
Circular dichroism analysis reveals helical structure of Asl 842-961 at an acidic pH  
Circular dichroism (CD) is a powerful technique that enables the determination of protein 
secondary structure in the near-UV CD spectrum. In order to determine structural changes, 
particularly in helical content, of Asl 842-961 as a function of pH, CD spectrum were obtained at 
three different pH conditions (pH 2.8, 4.85, and 7.5). Our CD analysis revealed that Asl 842-961 
remains structurally disordered at pH 4.85 and 7.5, but interestingly, helical ordered secondary 
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structure begins to emerge at pH 2.8 as shown by the characteristic peaks at 208 nm and 222 nm 
(Fig. 6). This result is in agreement with a previous study on the emergence of structure in 
centrosomal proteins through protein-protein interactions and pH changes at the centrosome 
(reference #38; see discussion).  
Isothermal titration calorimetry reveals a strong binding association between CaM and PACTP 
 In order to determine if further structural studies with our synthesized peptide PACTP were 
warranted, we wished to establish evidence of a binding association between CaM and PACTP. 
Using isothermal titration calorimetry (ITC), we quantified several variables involved in the 
association between CaM and PACTP. The raw data as well as a fitted curve to the titration of 
PACTP into CaM can be seen in Figure 7. The fitted curve indicates an exothermic reaction and 
favorable binding interactions. The stoichiometry between CaM and PACTP is approximately one 
(N = 1.33 ± 0.0164 sites). As determined from an association constant of 7.71 x 107 (K = 7.71 x 
107 ± 7.68 x 107 M-1), the dissociation constant, Kd, is approximately 13.0 nM, indicating a high 
affinity between PACTP and CaM. It is interesting to note that this association was observed in a 
buffer solution lacking the addition of free calcium, which also contained a chelating agent 
(EGTA) to bind any Ca2+ ions present in normally distilled water. This means that CaM was in an 
apo state (not bound to Ca2+ ions) when bound to PACTP. No conclusive results have yet been 
recorded for the affinity between CaM and PACTP when Ca2+ ions are present in the buffer 
solution.  
Protein fragments were screened independently and in various combinations for diffraction-
quality crystal growth 
We subjected varying concentrations of our purified protein fragments to a variety of salt 
and buffer conditions in attempts to harvest diffraction-quality crystals amenable for X-ray 
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crystallographic analysis. We were unable to use the entire third fragment of Asl due to the 
presence of multiple species (i.e. degradation products) during purification (Fig. 3). Asl F3 formed 
higher order species that maintained association even after being run through a denaturing gel. 
Therefore, a smaller fragment from amino acids 842-961 that lacks cysteine residues and 
eliminates predicted unstructured regions was chosen for crystallization trials. Exposed cysteine 
residues are capable of interacting with one another to form di-sulfide bonds (either within the 
same protein chain or between adjacent chains). The lack of cysteine residues aids in crystallization 
by preventing the formation of aberrant disulfide bonds. Disulfide bond formation could lead to 
incorrect or multiple folding configurations and thus folded protein fragments that are unable to 
pack into a uniform crystal structure. 
 Crystallization trials with CNN F1 alone as well as cocrystallization trials of CNN F1 with 
Asl 626-719 and Asl 842-961 were attempted. We predicted that binding interactions between Asl 
and CNN would help stabilize their respective structures and thus increase the likelihood of 
uniform crystal packing. Various molar ratios of Asl:CNN were screened due to a lack of 
stoichiometric binding information between Asl and CNN. It is necessary to create as homogenous 
a solution as possible for crystallization trials in order to eliminate any unbound protein molecules 
that may interfere with a uniform crystal arrangement. Therefore, by screening various molar 
ratios, we hoped to find a stoichiometric ratio between Asl and CNN that would remove excess 
unbound protein molecules from solution.   
 Finally, due to the strong binding association between CaM and PACTP indicated by our 
ITC results, cocrystallization trials were attempted for these binding partners. We based our 
screening conditions on a solved structure PDB ID 4DS7 for CaM bound by a peptide from the 
yeast spindle pole body protein Spc110 (37). This Spc110 peptide is a similar length to our peptide 
and its helical structure matches the predicted structure of PACTP.  
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To date, crystal growth of our protein fragments has yet to be observed. This lack of crystal 
growth could be due to a number of confounding variables such as poor binding interactions or the 
possible use of heterogeneous solutions in which unbound protein effectively blocks crystal 
packing. Another problem could be a lack of protein stability in solution, as precipitate was 
observed for most drops containing Asl, CNN, or Asl+CNN fragments indicating non-uniform 
packing of proteins. False positives can also lead to unfounded optimization of conditions. For 
example, Figure 8A-C shows crystal growth in drops containing Asl 626-719 and CNN F1. These 
crystals appeared several days prior to the appearance of similar crystals in control drops 
containing only buffer and well solution (Fig. 8 D-F). Figure 8C shows a crystal subjected to Blue 
Izit dye (Hampton) which protein crystals readily absorb while salt crystals exclude. Both the 
growth of crystals in the control drops as well as the exclusion of the blue dye by the crystal in the 
protein-containing drop indicate that these crystals are composed of salt ions, not proteins. 
Other PACT domains in yeast and human proteins show solubility 
Due to the limited solubility of PACTF and the lack of observed crystal growth for CaM 
with PACTP, we wished to determine if proteins from other species including S. pombe (Pcp1) 
and H. sapiens (PCNT and AKAP450) that contain canonical PACT domains were suitable for 
purification. Fragments of these PACT domains were cloned and tested for expression and 
solubility in E. coli BL21 cells (Fig. 9). Both Pcp1 fragments expressed at high levels and remained 
highly soluble after the cells were lysed by sonication. PCNT did not appear to express well after 
induction nor was there a soluble band observed by SDS-PAGE. AKAP450 showed slight 
expression and a possible soluble band; however, further purification will be necessary to 
determine the extent of its solubility. 
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Discussion: 
 The main goal of our structure-function studies was to elucidate high-resolution structural 
models of interacting centrosomal proteins through X-ray crystallography in order to more fully 
understand their function in centrosome regulation. We were able to confirm that our chosen 
fragments were suitable for crystallization trials through in vivo localization trials. We found 
robust centrosomal localization of Asl and CNN fragments during interphase demonstrating their 
ability to independently localize, most likely through interactions with other centrosomal proteins. 
This robust localization indicates that the protein fragments likely contain important binding 
and/or targeting domains, and thus these results warranted further crystallization studies. It should 
be noted, however, that these localization trials were not performed in a knock-down background, 
and therefore there remains the possibility of dimerization between the fragments and their 
respective full-length endogenously expressed proteins.  
A recent study explored Asl localization more in depth through depletion of endogenous 
Asl in S2 cells using RNAi targeting (39). Their chosen fragments (Asl-A aa 1-374, Asl-B aa 375-
630, Asl-C aa 631-994) were of similar length to our Asl F1, F2, and F3 (see Fig. 1). Interestingly, 
they found Asl-A and Asl-B to be largely diffuse and cytoplasmic with weak localization to 
centrioles, while Asl-C exhibited efficient colocalization with the centriole marker PLP. Taking 
these knock-down localization trials into consideration, it is likely that our Asl F1 and F2 are being 
targeted to the centrosome through homodimerization with endogenous Asl, but Asl F3 does 
indeed contain a domain sufficient to target Asl to the centrosome in vivo. The crystallization trials 
we chose to pursue focused on smaller fragments of Asl F3, and structural models of this fragment 
could help elucidate this targeting domain. However, structural models of Asl F1 and F2 will also 
be useful in determining the structural components of Asl that give rise to its scaffold or bridge-
like role at the centriole wall. 
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Another important consideration about Asl and CNN function lies in the fact that their 
localization was observed in interphase cells. We did not observe any Phosphohistone 3 staining 
used to stain mitotic chromatin for our cells, and therefore we were unable to observe if localization 
changes during mitosis. Asl and CNN are essential for proper centrosome regulation (28, 29, 31), 
and as the centrosome matures and expands its PCM throughout the cell cycle, it is likely that Asl 
and CNN are spatially controlled in order to temporally regulate their functional roles. It will be 
of great interest to determine if Asl and CNN levels change during different stages of the cell cycle.  
Due to the presence of unstructured regions within Asl F3, we chose to purify a smaller 
fragment, Asl 842-961, which eliminated these unstructured regions in order to aid in biochemical 
and structural analysis. CD analysis of Asl 842-961 revealed an intriguing structural feature of this 
fragment, which begins to exhibit its predicted helical structure at the acidic pH of 2.8 while 
remaining disordered at higher pH values (Fig. 3). This result is in agreement with a study by 
Trevino et al. (38) in which helical content for several centrosomal proteins was explored as a 
function of pH. They similarly found that all of the peptides tested became more structured at a 
lower pH. The study also found that this result held true regardless of the isoelectric point of the 
peptide, even for those with isoelectric points above 7 (predicted pI of Asl 842-961 = 8.23). The 
dependence of structural changes on pH could be due to an underlying mechanism of global 
regulation at the centrosome. The roles of centrosomal proteins remain dynamic throughout the 
cell cycle. The use of a centrosome wide pH variance during the cell cycle could result in more or 
less structured proteins, offering an attractive way to temporally regulate their functions. 
In an effort to fully characterize the important targeting domains of our centrosomal 
proteins, we chose to study the PACT domain of PLP. This domain is sufficient for centrosomal 
targeting and contains specific CaM binding sites (33). A recent study has shown that this 
interaction of CaM with the PACT domain is required for proper targeting of PLP to the 
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centrosome (35).  We were unable to purify Drosophila PACT (PACTF) alone due to its limited 
solubility, and therefore we had a small portion of the CaM-binding region within the PACT 
domain synthesized as a peptide (PACTP). Our ITC analysis indicated a high affinity between 
CaM and PACTP (Kd ~13 nM). We wish to replicate these results in order to reduce error. 
However, this initial result provided us with sufficient evidence to continue with crystallization 
trials. Interestingly, this interaction was observed in a calcium-free buffer with CaM in an apo 
state. Further ITC analysis in which Ca2+ ions are present and bound to CaM may provide 
insightful details concerning the effects of calcium binding on the affinity of CaM for the PACT 
domain of PLP. If future results indicate a weakened or ablated affinity between CaM and PACTP 
in the presence of calcium, it could indicate a potential regulatory mechanism in vivo in which 
CaM-PLP binding and thus PLP localization is dependent on changing calcium concentrations 
within the cell. 
With our biochemical analyses indicating that structural analysis could elucidate not only 
the functions of our chosen protein fragments but also their binding interactions with one another, 
we continued forward with crystallization trials. Obtaining diffraction-quality crystals would allow 
X-ray crystallographic analyses to be performed, through which highly structured crystals could 
produce nanometer-resolution structural models of our protein fragments. Because structure 
ultimately dictates function within the cell, having such high-resolution models would allow 
precise determination of the number and type of binding residues between centrosomal protein 
binding partners. They could also facilitate a deeper understanding of how certain structural 
domains within these proteins confer centrosome regulation. Many crystallization trials were 
performed on our protein fragments both independently and in combination with one another. No 
crystal growth for any of the fragments, including CaM with PACTP, has been observed. This 
could be due to a number of confounding variables, including but not limited to poor binding 
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interactions, long-term instability in solution, blocking of crystal packing from unbound protein 
molecules in our cocrystallization trials, improper concentrations, and the limited availability of 
broad screening buffer conditions.  
Despite not yet being able to crystallize Asl or CNN, our ITC analysis of PACTP has 
provided strong evidence that crystals can be produced for CaM and PACTP, especially 
considering the large number of solved CaM structures to date. A solved structure of this PACT 
peptide would indeed prove useful, however having a structure of a portion of endogenously 
expressed PACT would provide even more compelling evidence as to how CaM is targeting PLP 
to the centrosome. We will therefore continue forward with further solubility analysis and 
crystallization trials of CaM and PACTF. The solubility of the other PACT domains from yeast 
and humans (see Fig. 9) also allows us to continue with purification and crystallization trials of 
these PACT fragments independent of CaM, which can eventually afford the opportunity to 
compare the structures of CaM-bound vs. unbound PACT. 
Continuing structural studies of Asl, CNN, and PLP are crucial if we wish to fully 
understand how they are regulating the duplication and maturation of the centrosome and how 
their mutated structures are contributing to primordial dwarfism and microcephaly. The essential 
role of the centrosome in cell division makes it a worthy target of basic scientific research with the 
ultimate goal of obtaining a more complete understanding of this process. Although the 
centrosome is a highly complex organelle to which hundreds of proteins are recruited and 
organized, through a deep understanding of how its building blocks are interacting with one 
another, we can begin to piece together the larger picture of centrosome function.
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Figure 1. Schematic of protein fragments purified for localization and/or crystallization trials. 
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Figure 2. Multiple-sequence alignment of amino acids 2687-2796 in the PACT domain of PLP.  Highly 
conserved residues align with two Calmodulin-binding regions shown with red lines. A minimal region 
of this fragment containing the second CaM binding region was synthesized as PACTP. 
CaM binding region 1 CaM binding region 2 
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Figure 3. A) SDS-PAGE 
gel of purified Asl and 
CNN fragments. Note 
presence of multiple 
species in Asl F3 despite 
being run through a 
denaturing gel. B) SDS-
PAGE gel of purified Asl 
842-961 chosen in order 
to eliminate unstructured 
regions present within the 
full-length Asl F3. 
Figure 4. SDS-PAGE gel of 
CaM purified alone and with 
PACTF before and after 
digestion of the affinity tag with 
PreScission protease. Red boxes 
outline soluble CaM bands. 
Orange boxes outline soluble 
GST-PACTF in “HIS-
CAM+GST-PACT” lane and 
GST alone in “Digested 
CaM+PACTF” lane. Further 
analysis will determine if 
PACTF is remaining soluble 
after digestion of GST-tag. 
A) B) 
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Figure 5. Localization trials in Drosophila S2 cells of GFP-Asl and GFP-CNN 
fragments (green). The centrosome (marked by arrows) is labeled with 
endogenous PLP and Asl (red), respectively. Robust localization of all fragments 
to the centrosome indicates presence of targeting and/or binding domains within 
each fragment. 
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Figure 6. CD spectra of Asl 842-961 as a function of pH at 20°C. pH 2.8, red; pH 
4.85, green; pH 7.5, purple. Peaks at 208 nm and 222 nm marked with dotted lines 
indicate formation of helical structure within Asl 842-961 at pH 2.8. 
Figure 7. ITC analysis of CaM and PACTP. Top graph depicts changes in microcalories per 
second for each of twenty injections of PACTP into CaM in a Ca2+-free buffer. Bottom graph 
depicts fitted data used to determine stoichiometric ratios (N = 1.33±0.0164 sites), association 
constant (K = 7.71 x 107±7.68 x 107 M-1), enthalpy change (∆H = 1422±40.52 cal/mol) and 
entropy change (∆S = 40.8 cal/mol/deg). CaM and PACTP exhibit a strong binding association. 
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Figure 8. First optimization of cocrystal screen for Asl 626-719 and CNN 1-365. Top row shows 
representative crystals observed in protein-containing drops. Bottom row shows representative 
crystals observed in control (buffer + well) drops. The presence of crystals in the control drops 
indicates that the crystals in the protein-containing drops are likely composed of salt ions. The 
blue coloration in 8C is due to the presence of Izit dye (Hampton) which can penetrate protein 
crystals but not salt crystals. The crystal did not take up the dye which further indicates that it is 
composed of salt ions. 
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Figure 9. SDS-PAGE gel showing expression and solubility tests for several PACT-containing 
protein fragments from S. pombe (Pcp1) and H. sapiens (PCNT, AKAP450) fused with either 
a HIS- or GST-tag. Red boxes indicate expression in induced lanes and soluble fragments in 
supernatant lanes. Both Pcp1 fragments and the AKAP450 fragment expressed well and 
remained soluble. The red “X” indicates no expression nor soluble fragment observed for HIS-
PCNT 3119-3337. 
